Business
Health Catalyst, GIQuIC Team Up to Power the Nation's Only Gastroenterology-Focused Clinical Registry
SALT LAKE CITY, March 14, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology
About this update from Health Catalyst, Inc
[{"type":"text","content":"SALT LAKE CITY, March 14, 2023 /PRNewswire/ -- Health Catalyst, Inc. (\"Health Catalyst,\" Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a partnership with GI Quality Improvement Consortium, Inc. (GIQuIC), a joint collaboration of the American College of Gastroenterology (ACG) and American Society of Gastrointestinal Endoscopy (ASGE).\n\n \n \n \n \n \n \n\n \nAs noted in Health Catalyst's Q4 2022 earnings call announcement, GIQuiC which offers the only national gastroenterology-focused clinical registry, will utilize ARMUS by Health Catalyst's HYBRID Clinical Registry and Reporting solution to advance the extraction process, including a streamlined user experience, enhanced data capture process, and improved reporting.\n\"This collaboration will enhance the service we already provide to our registry participants by allowing GIQuIC to leverage the depth and breadth of offerings and prior experience and success Health Catalyst has with respect to registry services and healthcare analytics. The ultimate goal is to empower our users to improve the quality of the healthcare they provide to their patients,\" explained Costas H. Kefalas, MD, MMM, FACG, FASGE, President of the GIQuIC Board of Directors. \"This experience will be especially valuable as we enhance the registry functionality, add additional endoscopy procedures and digestive disease states, and facilitate patient-reported outcomes.\"\nBy leveraging ARMUS to reduce the registry data entry burden and simplify registry data management, GIQuIC will be best positioned to transition existing registry operations for colonoscopy and esophagogastroduodenoscopy (EGD) procedures by the beginning of 2024 with the goal of adding additional data collection and reporting relative to endoscopic procedures and disease states, to include inflammatory bowel disease (IBD), endoscopic retrograde cholangiopancreatography (ERCP), endoscopic bariatric therapy (EBT), endoscopic ultrasound (EUS), wireless capsule endoscopy and deep enteroscopy in the near future. With ARMUS, GIQuIC will achieve improved efficiency and data quality, while maintaining high-quality performance.\n\"Data abstraction and registry reporting are critical functions of healthcare organizations, and we are delighted GIQuIC has selected Health Cata...